What is this study studying for cervical and endometrial cancer pain?

This study is comparing two procedures, superior hypogastric plexus block and ganglion impar block, to see how well they manage pelvic and perineal pain caused by cervical and endometrial cancer. The goal is to find out which procedure may be more effective and safe for patients with this type of cancer pain. The University of Brawijaya is leading this research to improve pain management options.

Who may be eligible for this cervical and endometrial cancer pain clinical trial?

Women aged 18 years or older with pelvic or perineal pain from cervical or endometrial cancer may be eligible. Participants should have pain rated above 4 on a pain scale and have tried pain medications for at least 2 weeks without enough relief. Those with blood clotting disorders or local infections may not qualify. Please review eligibility criteria for more details.

Is there any cost to participate in this cervical and endometrial cancer pain clinical trial?

Study-related care, including the procedures and all trial visits, is provided at no cost. However, personal expenses like travel may not be covered and can vary. Participants should plan accordingly for any additional costs.

Actively Recruiting

Phase Not Applicable

Age: 18Years +

FEMALE

ID05427058

Comparing Superior Hypogastric Plexus Block and Ganglion Impar Block for Managing Pelvic and Perineal Pain in Cervical and Endometrial Cancer Patients

Led by University of Brawijaya · Updated on 2025-07-10

Participants Needed

Research Sites

17 weeks

Total Duration

AI-Summary

What this Trial Is About

Researchers are evaluating two procedures, superior hypogastric plexus block and ganglion impar block, to manage pelvic and perineal cancer pain in women with cervical and endometrial cancer. This randomized controlled trial aims to compare how effective and safe these two approaches are for patients suffering from cancer-related pain resistant to standard medication. The study uses a triple-blind design to ensure unbiased results.

CONDITIONS

Brief Title

Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management

Who Can Participate

Age: 18Years +

FEMALE

Eligibility Criteria

You may qualify if you...

Female patients aged over 18 years
Unbearable cancer pain resistant to World Health Organization pain ladder medication for at least 2 weeks
Tired of oral pain medication or experiencing complications such as respiratory depression, nausea, vomiting, opioid-induced constipation, or gastrointestinal disturbances
Pelvic floor pain diagnosed by a Fellow of Interventional Pain Practice-certified pain specialist
Perineal pain diagnosed by a Fellow of Interventional Pain Practice-certified pain specialist
Pain intensity greater than 4 on the Numerical Rating Scale
Able and willing to sign informed consent

You will not qualify if you...

Refusal to participate in the research
Blood clotting disorders, including current use of anticoagulant drugs
Local infection in the treatment area
Loss to follow-up
Occurrence of intervention complications
Failed intervention

Research Team

Ristiawan M Laksono, MD,FIPP

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Comparing Superior Hypogastric Plexus Block and Ganglion Impar Block for Managing Pelvic and Perineal Pain in Cervical and Endometrial Cancer Patients

On this page

AI-Summary

What this Trial Is About

Brief Title

Who Can Participate

Eligibility Criteria

Research Team

Not the Right Trial for You?

On this page

Who Can Participate

Eligibility Criteria